Tweaking the cholesterol efflux capacity of reconstituted HDL

Biochemistry and Cell Biology

Volumn 90, Issue 5, 2012, Pages 636-645

  Ma, Cheng I J ^a   Beckstead, Jennifer A ^b   Thompson, Airlia ^b   Hafiane, Anouar ^a   Wang, Rui Hao Leo ^a   Ryan, Robert O ^b   Kiss, Robert S ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

ABCA1; ABCG1; Apolipoprotein; Macrophage; Reverse cholesterol transport

Indexed keywords

ABCA1; ABCG1; APOLIPOPROTEINS; ATHEROSCLEROTIC LESIONS; CELL TYPES; CELLULAR CHOLESTEROL EFFLUX; CHO CELL; CHOLESTEROL EFFLUX; CHOLESTEROL TRANSPORT; FOAM CELLS; HEART DISEASE; HIGH-DENSITY LIPOPROTEINS; IN-VITRO; INTERVENTION STRATEGY; PHOSPHATIDYLCHOLINE; SPHINGOMYELIN; WILD TYPES;

CYTOLOGY; MACROPHAGES; PHOSPHOLIPIDS;

CHOLESTEROL;

ABC TRANSPORTER G1; APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE; SPHINGOMYELIN;

ANIMAL CELL; ARTICLE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; LIPOPROTEIN BLOOD LEVEL; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

ANIMALS; APOLIPOPROTEIN A-I; ATP-BINDING CASSETTE TRANSPORTERS; CELLS, CULTURED; CHO CELLS; CHOLESTEROL; CRICETINAE; LIPOPROTEINS, HDL; TRANSFECTION;

EID: 84865230750     PISSN: 08298211     EISSN: 12086002     Source Type: Journal    
DOI: 10.1139/o2012-015     Document Type: Article

References (57)

1. Alexander E.T. Tanaka M. Kono M. Saito H. Rader D.J. Phillips M.C. 2009 a. Structural and functional consequences of the Milano mutation (R173C) in human apolipoprotein A-I. J. Lipid Res. 50 (7): 1409-1419. 10.1194/jlr.M800578- JLR200 19318685
2. Alexander E.T. Weibel G.L. Joshi M.R. Vedhachalam C. de la Llera-Moya M. Rothblat G.H. et al. 2009 b. Macrophage reverse cholesterol transport in mice expressing ApoA-I Milano. Arterioscler. Thromb. Vasc. Biol. 29 (10): 1496-1501. 10.1161/ATVBAHA.109.191379 19661486
3. Ameli S. Hultgardh-Nilsson A. Cercek B. Shah P.K. Forrester J.S. Ageland H. Nilsson J. 1994. Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits. Circulation, 90 (4): 1935-1941. 10.1161/01.CIR.90.4.1935 7923682 (Pubitemid 24320945)
4. Bailey D. Jahagirdar R. Gordon A. Hafiane A. Campbell S. Chatur S. et al. 2010 a. RVX-208: a small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivo. J. Am. Coll. Cardiol. 55 (23): 2580-2589. 10.1016/j.jacc.2010.02.035 20513599
5. Bailey D. Ruel I. Hafiane A. Cochrane H. Iatan I. Jauhiainen M. et al. 2010 b. Analysis of lipid transfer activity between model nascent HDL particles and plasma lipoproteins: implications for current concepts of nascent HDL maturation and genesis. J. Lipid Res. 51 (4): 785-797. 10.1194/jlr.M001875 19797257
6. Bankston T.E. Carta G. 2010. Apolipoprotein A-I(Milano) anion exchange chromatography: Self association and adsorption equilibrium. Biotechnol. J. 5 (10): 1028-1039. 10.1002/biot.201000221 20931599
7. Bielicki J.K. McCall M.R. Stoltzfus L.J. Ravandi A. Kuksis A. Rubin E.M. Forte T.M. 1997. Evidence that apolipoprotein A-IMilano has reduced capacity, compared with wild-type apolipoprotein A-I, to recruit membrane cholesterol. Arterioscler. Thromb. Vasc. Biol. 17 (9): 1637-1643. 10.1161/01.ATV.17.9.1637 9327756 (Pubitemid 27423980)
8. Burgess B. Naus K. Chan J. Hirsch-Reinshagen V. Tansley G. Matzke L. et al. 2008. Overexpression of human ABCG1 does not affect atherosclerosis in fat-fed ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 28 (10): 1731-1737. 10.1161/ATVBAHA.108.168542 18599800
9. Calabresi L. Franceschini G. Burkybile A. Jonas A. 1997. Activation of lecithin cholesterol acyltransferase by a disulfide-linked apolipoprotein A-I dimer. Biochem. Biophys. Res. Commun. 232 (2): 345-349. 10.1006/bbrc.1997.6286 9125178 (Pubitemid 27216216)
10. Calabresi L. Tedeschi G. Treu C. Ronchi S. Galbiati D. Airoldi S. et al. 2001. Limited proteolysis of a disulfide-linked apoA-I dimer in reconstituted HDL. J. Lipid Res. 42 (6): 935-942. 11369801 (Pubitemid 32545849)
11. Calabresi L. Rossoni G. Gomaraschi M. Sisto F. Berti F. Franceschini G. 2003. High-density lipoproteins protect isolated rat hearts from ischemia-reperfusion injury by reducing cardiac tumor necrosis factor-alpha content and enhancing prostaglandin release. Circ. Res. 92 (3): 330-337. 10.1161/01.RES.0000054201.60308.1A 12595346 (Pubitemid 36258556)
12. Chiesa G. Monteggia E. Marchesi M. Lorenzon P. Laucello M. Lorusso V. et al. 2002. Recombinant apolipoprotein A-I(Milano) infusion into rabbit carotid artery rapidly removes lipid from fatty streaks. Circ. Res. 90 (9): 974-980. 10.1161/01.RES.0000018422.31717.EE 12016263 (Pubitemid 34633863)
13. Favari E. Gomaraschi M. Zanotti I. Bernini F. Lee-Rueckert M. Kovanen P.T. et al. 2007. A unique protease-sensitive high density lipoprotein particle containing the apolipoprotein A-I(Milano) dimer effectively promotes ATP-binding Cassette A1-mediated cell cholesterol efflux. J. Biol. Chem. 282 (8): 5125-5132. 10.1074/jbc.M609336200 17164237 (Pubitemid 47093758)
14. Franceschini G. Sirtori C.R. Capurso A. II Weisgraber K.H. Mahley R.W. 1980. A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family. J. Clin. Invest. 66 (5): 892-900. 10.1172/JCI109956 7430351 (Pubitemid 11233787)
15. Franceschini G. Calabresi L. Chiesa G. Parolini C. Sirtori C.R. Canavesi M. Bernini F. 1999. Increased cholesterol efflux potential of sera from ApoA-IMilano carriers and transgenic mice. Arterioscler. Thromb. Vasc. Biol. 19 (5): 1257-1262. 10.1161/01.ATV.19.5.1257 10323777 (Pubitemid 29227645)
16. Gelissen I.C. Harris M. Rye K.A. Quinn C. Brown A.J. Kockx M. et al. 2006. ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I. Arterioscler. Thromb. Vasc. Biol. 26 (3): 534-540. 10.1161/01.ATV.0000200082. 58536.e1 16357317
17. Ibanez B. Vilahur G. Cimmino G. Speidl W.S. Pinero A. Choi B.G. et al. 2008. Rapid change in plaque size, composition, and molecular footprint after recombinant apolipoprotein A-I Milano (ETC-216) administration: magnetic resonance imaging study in an experimental model of atherosclerosis. J. Am. Coll. Cardiol. 51 (11): 1104-1109. 10.1016/j.jacc.2007.09.071 18342230 (Pubitemid 351374767)
18. Kennedy M.A. Barrera G.C. Nakamura K. Baldan A. Tarr P. Fishbein M.C. et al. 2005. ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab. 1 (2): 121-131. 10.1016/j.cmet.2005.01.002 16054053 (Pubitemid 43977167)
19. Khovidhunkit W. Moser A.H. Shigenaga J.K. Grunfeld C. Feingold K.R. 2003. Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine macrophages: differential role of LXR. J. Lipid Res. 44 (9): 1728-1736. 10.1194/jlr.M300100-JLR200 12777468 (Pubitemid 37185884)
20. Kiss R.S. Maric J. Marcel Y.L. 2005. Lipid efflux in human and mouse macrophagic cells: evidence for differential regulation of phospholipid and cholesterol efflux. J. Lipid Res. 46 (9): 1877-1887. 10.1194/jlr.M400482-JLR200 15995179 (Pubitemid 41248484)
21. Kiss R.S. You Z. Genest J. Jr Behm D.J. Giaid A. 2011. Urotensin II differentially regulates macrophage and hepatic cholesterol homeostasis. Peptides, 32 (5): 956-963. 10.1016/j.peptides.2011.02.016 21376094
22. Kobayashi A. Takanezawa Y. Hirata T. Shimizu Y. Misasa K. Kioka N. et al. 2006. Efflux of sphingomyelin, cholesterol, and phosphatidylcholine by ABCG1. J. Lipid Res. 47 (8): 1791-1802. 10.1194/jlr.M500546-JLR200 16702602 (Pubitemid 44222830)
23. Li D. Weng S. Yang B. Zander D.S. Saldeen T. Nichols W.W. et al. 1999. Inhibition of arterial thrombus formation by ApoA1 Milano. Arterioscler. Thromb. Vasc. Biol. 19 (2): 378-383. 10.1161/01.ATV.19.2.378 9974422 (Pubitemid 29072754)
24. Marchesi M. Booth E.A. Davis T. Bisgaier C.L. Lucchesi B.R. 2004. Apolipoprotein A-IMilano and 1-palmitoyl-2-oleoyl phosphatidylcholine complex (ETC-216) protects the in vivo rabbit heart from regional ischemia-reperfusion injury. J. Pharmacol. Exp. Ther. 311 (3): 1023-1031. 10.1124/jpet.104.070789 15375174 (Pubitemid 39612707)
25. Marmillot P. Patel S. Lakshman M.R. 2007. Reverse cholesterol transport is regulated by varying fatty acyl chain saturation and sphingomyelin content in reconstituted high-density lipoproteins. Metabolism, 56 (2): 251-259. 10.1016/j.metabol.2006.09.021 17224341 (Pubitemid 46074073)
26. Martin D.D. Budamagunta M.S. Ryan R.O. Voss J.C. Oda M.N. 2006. Apolipoprotein A-I assumes a "looped belt" conformation on reconstituted high density lipoprotein. J. Biol. Chem. 281 (29): 20418-20426. 10.1074/jbc.M602077200 16698792 (Pubitemid 44065815)
27. Matsuo M. Campenot R.B. Vance D.E. Ueda K. Vance J.E. 2011. Involvement of low-density lipoprotein receptor-related protein and ABCG1 in stimulation of axonal extension by apoE-containing lipoproteins. Biochim. Biophys. Acta, 1811 (1): 31-38. 10.1016/j.bbalip.2010.10.004 21040802
28. Mukhamedova N. Escher G. D'Souza W. Tchoua U. Grant A. Krozowski Z. et al. 2008. Enhancing apolipoprotein A-I-dependent cholesterol efflux elevates cholesterol export from macrophages in vivo. J. Lipid Res. 49 (11): 2312-2322. 10.1194/jlr.M800095-JLR200 18622028
29. Nicholls S.J. Tuzcu E.M. Sipahi I. Schoenhagen P. Crowe T. Kapadia S. Nissen S.E. 2006. Relationship between atheroma regression and change in lumen size after infusion of apolipoprotein A-I Milano. J. Am. Coll. Cardiol. 47 (5): 992-997. 10.1016/j.jacc.2005.11.040 16516083
30. Nissen S.E. Tsunoda T. Tuzcu E.M. Schoenhagen P. Cooper C.J. Yasin M. et al. 2003. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA, 290 (17): 2292-2300. 10.1001/jama.290.17.2292 14600188 (Pubitemid 37430562)
31. Out R. Hoekstra M. Hildebrand R.B. Kruit J.K. Meurs I. Li Z. et al. 2006. Macrophage ABCG1 deletion disrupts lipid homeostasis in alveolar macrophages and moderately influences atherosclerotic lesion development in LDL receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 26 (10): 2295-2300. 10.1161/01.ATV.0000237629.29842.4c 16857950 (Pubitemid 44465725)
32. Out R. Hoekstra M. Habets K. Meurs I. de Waard V. Hildebrand R.B. et al. 2008. Combined deletion of macrophage ABCA1 and ABCG1 leads to massive lipid accumulation in tissue macrophages and distinct atherosclerosis at relatively low plasma cholesterol levels. Arterioscler. Thromb. Vasc. Biol. 28 (2): 258-264. 10.1161/ATVBAHA.107.156935 18006857 (Pubitemid 351161197)
33. Parolini C. Marchesi M. Lorenzon P. Castano M. Balconi E. Miragoli L. et al. 2008. Dose-related effects of repeated ETC-216 (recombinant apolipoprotein A-I Milano/1-palmitoyl-2-oleoyl phosphatidylcholine complexes) administrations on rabbit lipid-rich soft plaques: in vivo assessment by intravascular ultrasound and magnetic resonance imaging. J. Am. Coll. Cardiol. 51 (11): 1098-1103. 10.1016/j.jacc.2007.12.010 18342229 (Pubitemid 351374769)
34. Perez-Mendez O. Bruckert E. Franceschini G. Duhal N. Lacroix B. Bonte J.P. et al. 2000. Metabolism of apolipoproteins AI and AII in subjects carrying similar apoAI mutations, apoAI Milano and apoAI Paris. Atherosclerosis, 148 (2): 317-325. 10.1016/S0021-9150(99)00279-8 10657568 (Pubitemid 30064463)
35. Ranalletta M. Wang N. Han S. Yvan-Charvet L. Welch C. Tall A.R. 2006. Decreased atherosclerosis in low-density lipoprotein receptor knockout mice transplanted with Abcg1-/- bone marrow. Arterioscler. Thromb. Vasc. Biol. 26 (10): 2308-2315. 10.1161/01.ATV.0000242275.92915.43 16917103 (Pubitemid 44465727)
36. Ryan R.O. Forte T.M. Oda M.N. 2003. Optimized bacterial expression of human apolipoprotein A-I. Protein Expr. Purif. 27 (1): 98-103. 10.1016/S1046-5928(02)00568-5 12509990 (Pubitemid 37096475)
37. Rye K.A. Hime N.J. Barter P.J. 1996. The influence of sphingomyelin on the structure and function of reconstituted high density lipoproteins. J. Biol. Chem. 271 (8): 4243-4250. 10.1074/jbc.271.8.4243 8626769 (Pubitemid 26070528)
38. Sankaranarayanan S. Oram J.F. Asztalos B.F. Vaughan A.M. Lund-Katz S. Adorni M.P. et al. 2009. Effects of acceptor composition and mechanism of ABCG1-mediated cellular free cholesterol efflux. J. Lipid Res. 50 (2): 275-284. 10.1194/jlr.M800362-JLR200 18827283
39. Sano O. Kobayashi A. Nagao K. Kumagai K. Kioka N. Hanada K. et al. 2007. Sphingomyelin-dependence of cholesterol efflux mediated by ABCG1. J. Lipid Res. 48 (11): 2377-2384. 10.1194/jlr.M700139-JLR200 17761632 (Pubitemid 350058749)
40. Shah P.K. Yano J. Reyes O. Chyu K.Y. Kaul S. Bisgaier C.L. et al. 2001. High-dose recombinant apolipoprotein A-I(milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization. Circulation, 103 (25): 3047-3050. 10.1161/hc2501.092494 11425766 (Pubitemid 32587849)
41. Soma M.R. Donetti E. Parolini C. Sirtori C.R. Fumagalli R. Franceschini G. 1995. Recombinant apolipoprotein A-IMilano dimer inhibits carotid intimal thickening induced by perivascular manipulation in rabbits. Circ. Res. 76 (3): 405-411. 10.1161/01.RES.76.3.405 7859387
42. Tarling E.J. Bojanic D.D. Tangirala R.K. Wang X. Lovgren-Sandblom A. Lusis A.J. et al. 2010. Impaired development of atherosclerosis in Abcg1-/- Apoe-/- mice: identification of specific oxysterols that both accumulate in Abcg1-/- Apoe-/- tissues and induce apoptosis. Arterioscler. Thromb. Vasc. Biol. 30 (6): 1174-1180. 10.1161/ATVBAHA.110.205617 20299684
43. Vaughan A.M. Oram J.F. 2005. ABCG1 redistributes cell cholesterol to domains removable by high density lipoprotein but not by lipid-depleted apolipoproteins. J. Biol. Chem. 280 (34): 30150-30157. 10.1074/jbc.M505368200 15994327 (Pubitemid 41216193)
44. Vaughan A.M. Oram J.F. 2006. ABCA1 and ABCG1 or ABCG4 act sequentially to remove cellular cholesterol and generate cholesterol-rich HDL. J. Lipid Res. 47 (11): 2433-2443. 10.1194/jlr.M600218-JLR200 16902247 (Pubitemid 44936105)
45. Wang W.Q. Moses A.S. Francis G.A. 2001. Cholesterol mobilization by free and lipid-bound apoAI(Milano) and apoAI(Milano)-apoAII heterodimers. Biochemistry, 40 (12): 3666-3673. 10.1021/bi002141j 11297434 (Pubitemid 32242824)
46. Wang N. Lan D. Chen W. Matsuura F. Tall A.R. 2004. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc. Natl. Acad. Sci. U.S.A. 101 (26): 9774-9779. 10.1073/pnas.0403506101 15210959 (Pubitemid 38869312)
47. Wang L. Sharifi B.G. Pan T. Song L. Yukht A. Shah P.K. 2006. Bone marrow transplantation shows superior atheroprotective effects of gene therapy with apolipoprotein A-I Milano compared with wild-type apolipoprotein A-I in hyperlipidemic mice. J. Am. Coll. Cardiol. 48 (7): 1459-1468. 10.1016/j.jacc.2006.07.040 17010811 (Pubitemid 44468006)
48. Wang X. Collins H.L. Ranalletta M. Fuki I.V. Billheimer J.T. Rothblat G.H. et al. 2007. Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. J. Clin. Invest. 117 (8): 2216-2224. 10.1172/JCI32057 17657311 (Pubitemid 47219566)
49. Weers P.M. Patel A.B. Wan L.C. Guigard E. Kay C.M. Hafiane A. et al. 2011. Novel N-terminal mutation of human apolipoprotein A-I reduces self-association and impairs LCAT activation. J. Lipid Res. 52 (1): 35-44. 10.1194/jlr.M007500 20884842
50. Weibel G.L. Alexander E.T. Joshi M.R. Rader D.J. Lund-Katz S. Phillips M.C. Rothblat G.H. 2007. Wild-type ApoA-I and the Milano variant have similar abilities to stimulate cellular lipid mobilization and efflux. Arterioscler. Thromb. Vasc. Biol. 27 (9): 2022-2029. 10.1161/ATVBAHA.107.148403 17615385 (Pubitemid 47312313)
51. Wiersma H. Nijstad N. de Boer J.F. Out R. Hogewerf W. Van Berkel T.J. et al. 2009. Lack of Abcg1 results in decreased plasma HDL cholesterol levels and increased biliary cholesterol secretion in mice fed a high cholesterol diet. Atherosclerosis, 206 (1): 141-147. 10.1016/j.atherosclerosis.2009.02.022 19339012
52. Wu Z. Wagner M.A. Zheng L. Parks J.S. Shy J.M. III Smith J.D. et al. 2007. The refined structure of nascent HDL reveals a key functional domain for particle maturation and dysfunction. Nat. Struct. Mol. Biol. 14 (9): 861-868. 10.1038/nsmb1284 17676061 (Pubitemid 47373831)
53. Wu Z. Gogonea V. Lee X. Wagner M.A. Li X.M. Huang Y. et al. 2009. Double superhelix model of high density lipoprotein. J. Biol. Chem. 284 (52): 36605-36619. 10.1074/jbc.M109.039537 19812036
54. Yvan-Charvet L. Ranalletta M. Wang N. Han S. Terasaka N. Li R. et al. 2007. Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice. J. Clin. Invest. 117 (12): 3900-3908. 17992262 (Pubitemid 350224099)
55. Yvan-Charvet L. Wang N. Tall A.R. 2010. Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. Arterioscler. Thromb. Vasc. Biol. 30 (2): 139-143. 10.1161/ATVBAHA.108.179283 19797709
56. Zhao X.Q. Brown B.G. 2008. ApoA-I(Milano)/phospholipid complex: clinical implications of dose-response studies in rabbit atherosclerosis with intravascular ultrasound and magnetic resonance imaging. J. Am. Coll. Cardiol. 51 (11): 1110-1111. 10.1016/j.jacc.2007.12.012 18342231 (Pubitemid 351374772)
57. Zhu X. Wu G. Zeng W. Xue H. Chen B. 2005. Cysteine mutants of human apolipoprotein A-I: a study of secondary structural and functional properties. J. Lipid Res. 46 (6): 1303-1311. 10.1194/jlr.M400401-JLR200 15805548 (Pubitemid 43109845)